These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8912566)

  • 1. Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure.
    Lowe NJ; Wieder JM; Rosenbach A; Johnson K; Kunkel R; Bainbridge C; Bourget T; Dimov I; Simpson K; Glass E; Grabie MT
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):710-9. PubMed ID: 8912566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study.
    Ho VC; Griffiths CE; Berth-Jones J; Papp KA; Vanaclocha F; Dauden E; Beard A; Puvanarajan L; Paul C
    J Am Acad Dermatol; 2001 Apr; 44(4):643-51. PubMed ID: 11260540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.
    Isnard Bagnis C; Tezenas du Montcel S; Beaufils H; Jouanneau C; Jaudon MC; Maksud P; Mallet A; LeHoang P; Deray G
    J Am Soc Nephrol; 2002 Dec; 13(12):2962-8. PubMed ID: 12444215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effects of maintenance low-dose cyclosporin A treatment in psoriasis.
    Svarstad E; Helland S; Morken T; Bostad L; Myking A; Iversen BM; Ofstad J
    Nephrol Dial Transplant; 1994; 9(10):1462-7. PubMed ID: 7816261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin.
    Young EW; Ellis CN; Messana JM; Johnson KJ; Leichtman AB; Mihatsch MJ; Hamilton TA; Groisser DS; Fradin MS; Voorhees JJ
    Kidney Int; 1994 Oct; 46(4):1216-22. PubMed ID: 7861719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine.
    Pei Y; Scholey JW; Katz A; Schachter R; Murphy GF; Cattran D
    Am J Kidney Dis; 1994 Apr; 23(4):528-36. PubMed ID: 8154488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function after 10 years' treatment with cyclosporin for psoriasis.
    Powles AV; Hardman CM; Porter WM; Cook T; Hulme B; Fry L
    Br J Dermatol; 1998 Mar; 138(3):443-9. PubMed ID: 9580797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety of cyclosporine in the treatment of psoriasis.
    Grossman RM; Chevret S; Abi-Rached J; Blanchet F; Dubertret L
    Arch Dermatol; 1996 Jun; 132(6):623-9. PubMed ID: 8651712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphologic renal changes during cyclosporine treatment of psoriasis. Studies on pretreatment and posttreatment kidney biopsy specimens.
    Zachariae H; Hansen HE; Kragballe K; Olsen S
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):415-9. PubMed ID: 1564147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal biopsy in connection with long-term treatment of psoriasis with cyclosporine].
    Zachariae H; Kragballe K; Hansen HE; Marcussen N; Olsen S
    Ugeskr Laeger; 1998 Jul; 160(31):4534-8. PubMed ID: 9700311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
    Drugs R D; 2007; 8(2):103-12. PubMed ID: 17324008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term low-dose cyclosporine therapy for psoriasis.
    Campbell JL; Zug KA
    J Am Acad Dermatol; 1997 Oct; 37(4):671-2. PubMed ID: 9344222
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal function and biopsy findings after 5 years' treatment with low-dose cyclosporin for psoriasis.
    Powles AV; Cook T; Hulme B; Baker BS; Lewis HM; Thomas E; Valdimarsson H; Fry L
    Br J Dermatol; 1993 Feb; 128(2):159-65. PubMed ID: 8457449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal structure and function effects after low dose cyclosporine in psoriasis patients: a preliminary report.
    Messana JM; Johnson KJ; Mihatsch MJ
    Clin Nephrol; 1995 Mar; 43(3):150-3. PubMed ID: 7774069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal biopsy findings in long-term cyclosporin treatment of psoriasis.
    Zachariae H; Kragballe K; Hansen HE; Marcussen N; Olsen S
    Br J Dermatol; 1997 Apr; 136(4):531-5. PubMed ID: 9155953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can maintenance cyclosporine be used in psoriasis without decreasing renal function?
    Silverman AK; Emmett M; Menter A
    Semin Dermatol; 1992 Dec; 11(4):302-12. PubMed ID: 1493094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
    Feutren G; Mihatsch MJ
    N Engl J Med; 1992 Jun; 326(25):1654-60. PubMed ID: 1588978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.
    Borghi A; Corazza M; Mantovani L; Bertoldi AM; Giari S; Virgili A
    Int J Dermatol; 2012 Dec; 51(12):1512-6. PubMed ID: 23171021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy.
    Landewé RB; Dijkmans BA; van der Woude FJ; Breedveld FC; Mihatsch MJ; Bruijn JA
    J Rheumatol; 1996 Jan; 23(1):61-4. PubMed ID: 8838509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.